Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Injection
100%
Visual Acuity
88%
Vitrectomy
71%
Intravitreal Administration
70%
Retinal Detachment
63%
Optical Coherence Tomography
58%
Pars Plana Vitrectomy
49%
Macular Hole
43%
Bevacizumab
42%
Epiretinal Membrane
41%
Vasculotropin
33%
Age Related Macular Degeneration
31%
Dexamethasone
29%
Retinopexy
28%
Cataract Surgery
26%
Best Corrected Visual Acuity
25%
Macular Edema
24%
Intraocular Pressure
22%
Ophthalmology
22%
Retrospective Study
21%
Wet Macular Degeneration
20%
Subretinal Fluid
19%
Visual Impairment
19%
Elderly Patient
18%
Diabetic Macular Edema
18%
Retina Disease
18%
Internal Limiting Membrane
16%
Anterior Chamber of Eyeball
15%
Maculopathy
15%
Endophthalmitis
15%
Retina Vein Occlusion
15%
Cataract
15%
Silicone Oil
15%
Magnetic Resonance Imaging
14%
Scleral Buckle
14%
Computer Assisted Tomography
14%
Eye Injury
14%
Endothelial Cell Growth Factor
14%
Stem Cell
13%
Choroidal Neovascularization
13%
Retinal Vein Occlusion
13%
Glaucoma
13%
Cell Therapy
12%
Pathogenesis
12%
Hematopoietic Cell
12%
Tissue Plasminogen Activator
11%
Eye Disease
11%
Ranibizumab
10%
Central Retinal Vein Occlusion
10%
Branch Retinal Vein Occlusion
10%
Keyphrases
Intravitreal Injection
92%
Visual Acuity
75%
Intravitreal Ranibizumab
61%
Bevacizumab
50%
Age-related Macular Degeneration
39%
Pars Plana Vitrectomy
38%
Diabetic Macular Edema
36%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
35%
Vitrectomy
33%
Ozurdex
29%
Best-corrected Visual Acuity
28%
Most Cited Papers
28%
Macular Edema
27%
Subretinal Fluid
26%
Intraocular Pressure
25%
Syrinx
25%
Retinal Vein Occlusion
24%
Ranibizumab
24%
Ophthalmologist
24%
Macular Hole
24%
Retinal Diseases
24%
Retinal Thickness
23%
Neovascular Age-related Macular Degeneration (nAMD)
23%
Retinal Detachment
23%
Intravitreal
22%
Laser Retinopexy
21%
Central Macular Thickness
19%
Optical Coherence Tomography
19%
Topical Bevacizumab
18%
Cardiac Magnetic Resonance Imaging (cMRI)
17%
Choroidal Thickness
17%
Intravitreal Administration
16%
Ophthalmology
16%
Cataract Extraction
16%
Anti-VEGF Therapy
16%
Intraocular Pressure Reduction
15%
Epiretinal Membrane
14%
Prefilled Syringe
14%
Computed Tomography
14%
Drug Delivery
14%
Rhegmatogenous Retinal Detachment
14%
Young Patients
14%
Response to Treatment
14%
Operative
14%
Imaging Tomography
14%
Exudative Age-related Macular Degeneration
14%
Accuracy Evaluation
14%
Phakic
14%
Brimonidine Tartrate
14%
Filling Process
14%